Operating Income - Cytosorbents Corp (NASDAQ:CTSO) - Alpha Spread

Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager
Cytosorbents Corp Logo
Cytosorbents Corp
NASDAQ:CTSO
Watchlist
Price: 1.42 USD Market Closed
Market Cap: 77.1m USD
Have any thoughts about
Cytosorbents Corp?
Write Note

Cytosorbents Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytosorbents Corp
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Cytosorbents Corp
NASDAQ:CTSO
Operating Income
-$24.1m
CAGR 3-Years
-25%
CAGR 5-Years
-8%
CAGR 10-Years
-19%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.7B
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.6B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.7B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
13%

See Also

What is Cytosorbents Corp's Operating Income?
Operating Income
-24.1m USD

Based on the financial report for Jun 30, 2024, Cytosorbents Corp's Operating Income amounts to -24.1m USD.

What is Cytosorbents Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-19%

Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Cytosorbents Corp have been -25% over the past three years , -8% over the past five years , and -19% over the past ten years .

Back to Top